Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis Australia 
        • Therapeutic areas of Novartis 
        • Company History 
      • Strategy 
      • People and Culture 
      • Product Portfolio 
        • Products - Consumer Information 
        • Products - Healthcare Professionals 
      • Our Business 
      • Contact 
      About Novartis Australia
      About
    • Patients and Caregivers 
      • How to Report Adverse Events 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Products - Consumer Information 
      • Access our medicines 
      Patients and Caregivers
      Patients and Caregivers
    • Healthcare Professionals 
      • Adverse Event Reporting for Healthcare Professionals 
      • Healthcare professional country resource 
      • Products - Healthcare Professionals 
      • Novartis Pipeline 
      • Novartis Clinical Trials 
      Healthcare Professionals
      Healthcare Professionals
    • ESG 
      • Financial Transparency for Australia 
      • Financial Transparency for New Zealand 
      • Grants 
      • Diversity, Equity and Inclusion 
        • Our Reconciliation Action Plan 
      • Patient Groups 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
        • Modern Slavery Statement 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Environment, Society and Governance
      ESG
    • News 
      • News Archive 
      • Media Contacts 
      News
      News
    • Careers 
      • Career Search 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • How We Work 
      • Diversity and Inclusion 
      • Career Programs 
      • Graduate Program 
      • Learning and Development 
      Team member
      Careers
    Novartis in Australia
    Home
Header
Healthcare Professionals

Healthcare Professionals

Providing support and seeking collaboration

Novartis works closely with healthcare professionals around the work to support their treatment of patients and collaborate on unmet needs.
Healthcare professional country resource card

Healthcare professional country resource

Novartis provides information and resources through country HCP portals.

Products

Products - Healthcare Professionals

Learn more about treatments currently offered by Novartis Innovative Medicines, Sandoz and Advanced Accelerator Applications.

Novartis pipeline card

Novartis Pipeline

Our industry leading portfolio is focused on transforming the standard of care for patients worldwide.

Adverse event reporting card

Adverse Event Reporting for Healthcare Professionals

Novartis has a systematic process in place to collect, store and process reports of adverse events experienced by patients taking a Novartis product.

Novartis clinical trials

Novartis Clinical Trials

Novartis is working closely with healthcare professionals to bring clinical trials closer.

Novartis Australia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Contacts
Our Portfolio
  • Products - Consumer Information
  • Products - Healthcare Professionals
Other Novartis Websites
  • Novartis Global
  • MedHub AU
Footer Bottom
© 2025 Novartis Pharmaceuticals Australia Pty Ltd.
  • Privacy Policy
  • Terms of Use
  • Web Accessibility
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in Australia